Gosset Ownership
Private
Therapeutic Areas
Stage
Preclinical
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Vanudis General Information
Vanudis is a biotechnology company focused on developing novel proprietary immunotherapeutics. Leveraging expertise in generating stable humanized antibodies and creating phage display libraries from unique donor sources, Vanudis develops innovative therapeutic classes such as CAR cell therapies, ImmunoRNAses, and innate immune-derived antibodies. The company's approach spans early preclinical research through translational steps toward clinical application. Specific pipeline programs or late-stage results are not disclosed publicly.
Contact Information
Drug Pipeline
No pipeline data available
Key Partnerships
Vanudis Funding
No funding data available
To view Vanudis's complete valuation and funding history, request access »